CNGB1
CNGB1 provides the instructions for part of a channel inside rod photoreceptors, the cells at the back of the eye that make vision possible in dim light. When both inherited copies of this gene carry disease-causing changes, the result is an autosomal recessive form of retinitis pigmentosa, a slowly progressive rod-cone dystrophy sometimes called RP45. Night blindness usually begins early in life, but the disease tends to progress slowly, and useful central vision is often kept well into adulthood. Some people with CNGB1-related disease also have a reduced or absent sense of smell. As of the date of this review, no treatment targeting CNGB1 has been approved, although gene therapy has restored rod function in dogs and a natural history study has been registered.
- Disease Category
- autosomal recessive
Where things stand · Treatment
Treatment & research
No therapy specifically targeting CNGB1 has been approved to date.
Where things stand · Clinical trials
Studies that may be relevant to review
One registered study, CNGB1 and Allied Disorders (NCT04639635), is a natural history study designed to better understand how CNGB1-related disease progresses in order to support future treatment…
Check current clinical trials for this gene — the Finder pulls live studies from ClinicalTrials.gov.
Find clinical trialsOpens the Clinical Trials Finder with this gene — you can change or remove it.What this gene means
The CNGB1 gene carries the code for the beta subunit (a specific protein chain that combines with one or more other subunits, often an alpha subunit, to form a…
The CNGB1 gene carries the code for the beta subunit (a specific protein chain that combines with one or more other subunits, often an alpha subunit, to form a complete, functional multi-subunit protein or enzyme) of the cyclic nucleotide-gated channel (a type of channel found in cell membranes that opens when internal chemical messengers bind to it) in rod photoreceptors. Rods are the light-detecting cells responsible for night and peripheral vision, and this channel controls the flow of charged particles into the rod in response to light. When the channel does not work properly, rods gradually stop functioning and then degenerate, which is why defects in this gene cause retinitis pigmentosa. This condition is inherited in an pattern, meaning a person is affected only when both copies of the gene carry a disease-causing change.
How it may affect vision
The first symptom is typically difficulty seeing in dim light.
The first symptom is typically difficulty seeing in dim light. This often appears in childhood. Because the degeneration is slow, many people are not formally diagnosed with retinitis pigmentosa until their thirties or forties. Electrical testing of the retina in these patients confirms a rod-cone pattern, meaning rod function is lost first and cone function follows. A notable feature of CNGB1-related disease is that sharp central vision and the central retinal structure are often preserved into adult life. The way the disease appears can vary between individuals, and researchers have described at least one unusual case with isolated rod dysfunction rather than the typical rod-cone picture.
What is known
CNGB1 is a well-established cause of autosomal recessive retinitis pigmentosa in one cohort study, accounting for roughly 4% of those RP cases.
CNGB1 is a well-established cause of retinitis pigmentosa in one cohort study, accounting for roughly 4% of those RP cases. However, it is a rare cause overall, with prevalence varying across populations. Certain recurring variants are enriched in specific groups, such as individuals who are ethnically Chinese. A large review has catalogued 84 different disease-causing changes in CNGB1, reflecting many years of genetic study. Studies comparing CNGA1- and CNGB1-related disease describe both as slowly progressive forms of retinitis pigmentosa. Researchers have also identified an autosomal recessive syndrome combining retinitis pigmentosa with impaired smell, because the channel is expressed both in rods and in olfactory (smell) sensory neurons.
What is uncertain
The link between CNGB1 changes and loss of smell is not uniform, and in one multiethnic cohort the patients whose sense of smell was preserved all carried at…
The link between CNGB1 changes and loss of smell is not uniform, and in one multiethnic cohort the patients whose sense of smell was preserved all carried at least one missense variant. Some CNGB1 variants remain of uncertain significance and require laboratory testing, such as splicing studies, to clarify whether they actually cause disease. A rare additional complication called Coats-like exudative retinal vasculopathy has been reported alongside CNGB1 mutations, but this appears uncommon. Because the slowly progressive natural course is best understood from relatively small case series, individual progression cannot be predicted precisely.
Treatment & research
No therapy specifically targeting CNGB1 has been approved to date.
No therapy specifically targeting CNGB1 has been approved to date. In laboratory research, a gene augmentation therapy delivered under the retina restored rod-driven retinal function and vision in dogs carrying CNGB1 mutations for at least a year after treatment. This is animal research and not an available treatment, but it supports continued development toward human trials. The slow loss of rod cells in CNGB1 disease is thought to create a relatively wide window of opportunity for future therapies, which is one reason this form is considered a promising target for . Supporting this idea, work in a CNGB1 mouse model showed that cone photoreceptors kept sending useful visual signals to the brain until very late in rod degeneration.
Gene therapy tested in dogs with CNGB1 mutations
Animal (preclinical) research- What was found:
- The treatment restored rod-driven retinal responses and vision for at least 12 months and corrected the underlying channel defect.
- Why it matters:
- It supports moving this approach toward human clinical development.
Limitation: Results in dogs may not translate directly to people, and this is not an available treatment.
A comprehensive review of CNGB1 variants and disease features
Review with pooled human phenotype data- What was found:
- They catalogued 84 variants in total and confirmed that this form of retinitis pigmentosa retains useful central vision for a long time despite early night blindness.
- Why it matters:
- It provides counseling information and supports CNGB1 as a priority candidate for gene therapy trials.
Limitation: Pooled data from many sources vary in how thoroughly each patient was assessed.
Detailed clinical characterization of CNGB1-related retinitis pigmentosa
Human case series- What was found:
- Night blindness began in childhood, visual field loss appeared later, and best-corrected visual acuity plus central retinal structure were preserved into adulthood.
- Why it matters:
- It suggests a lengthy window during which future therapies could be applied.
Limitation: Small number of patients and relatively short average follow-up.
Loss of smell in CNGB1-associated retinitis pigmentosa
Human case series- What was found:
- All had early night blindness and slow retinal degeneration, and nearly all had reduced or absent smell.
- Why it matters:
- It established that CNGB1 can cause a combined retinitis pigmentosa and smell-dysfunction syndrome.
Limitation: Very small sample and detailed brain imaging available for only one patient.
Comparing CNGA1- and CNGB1-related retinitis pigmentosa
Human observational cohort- What was found:
- Both CNGA1 and CNGB1 forms were slowly progressive, with comparable visual acuity between the two groups.
- Why it matters:
- The slow course reinforces the potential suitability of these conditions for gene augmentation therapy.
Limitation: Retrospective design and modest number of patients.
For family & caregivers
Beyond the shared guidance shown on every gene page, two CNGB1-specific points are worth knowing.
Beyond the shared guidance shown on every gene page, two CNGB1-specific points are worth knowing. Night blindness often begins in childhood, so a child may struggle in dim light long before a formal diagnosis is made. A reduced or absent sense of smell can accompany this condition, which has everyday safety implications such as difficulty detecting smoke, gas leaks, or spoiled food, and may be worth discussing with the care team.
Questions to ask your clinician
Questions to bring to a retinal specialist or genetic counselor…
- Do my specific CNGB1 variants have a known effect on how the disease typically progresses?
- Given the slow progression often reported, how frequently should my vision be monitored?
- Would testing my sense of smell be useful in my case?
- Are there signs of rarer complications, such as Coats-like retinal changes, that I should watch for?
- What does my result mean for my children, siblings, or other relatives?
- How would I learn about future gene therapy research or natural history studies relevant to CNGB1?
What you can do next
Confirming the diagnosis through genetic testing and reviewing the specific variants with a genetic counselor can clarify what a CNGB1 result means for you and…
Confirming the diagnosis through genetic testing and reviewing the specific variants with a genetic counselor can clarify what a CNGB1 result means for you and your family. A retinal specialist can monitor how your vision changes over time and discuss whether measuring your sense of smell is worthwhile. If you are interested in research studies, RP Hope's Clinical Trials Finder can help screen for options with CNGB1 in mind.
Sources
Peer-reviewed and registry references underlying this page…
- CNGB1 cyclic nucleotide gated channel subunit beta 1
- Olfactory Dysfunction in Patients With CNGB1-Associated Retinitis Pigmentosa
- Homozygosity mapping and targeted Sanger sequencing reveal genetic defects underlying inherited retinal disease in families from Pakistan
- CNGB1-related rod-cone dystrophy: A mutation review and update
- Clinical exome sequencing for inherited retinal degenerations at a tertiary care center
- Diagnostic Role of Chromatic Full-Field Stimulus Test in Rod-Cone Versus Cone Dystrophies
- Robust cone-mediated signaling persists late into rod photoreceptor degeneration
- Selective Knockout of Murine GARP2 Significantly Alters Cellular Dark Noise in Rod Photoreceptors
- Selective knockout of murine GARP2 significantly alters dark continuous noise in rod photoreceptors
- Development of a translatable gene augmentation therapy for CNGB1-retinitis pigmentosa
- Retinal degeneration in mice lacking the cyclic nucleotide-gated channel subunit CNGA1
- Clinical Exome Sequencing for Inherited Retinal Disorders at a Tertiary Care Center
- Clinical Characterization of CNGB1-Related Autosomal Recessive Retinitis Pigmentosa
- Mutational Spectrum, Ocular and Olfactory Phenotypes of CNGB1-Related RP-Olfactory Dysfunction Syndrome in a Multiethnic Cohort
- Isolated rod dysfunction associated with a novel genotype of CNGB1
- Genotypic and Phenotypic Characterization of a Cohort of Patients Affected by Rod Cyclic Nucleotide Channel-Associated Retinitis Pigmentosa
- Bilateral Macular Dysplasia in Coffin-Siris Syndrome
- Clinical spectrum, genetic associations and management outcomes of Coats-like exudative retinal vasculopathy in autosomal recessive retinitis pigmentosa
- Functional Evaluation of Splicing for Variants of Uncertain Significance in Patients with Inherited Retinal Diseases
- Next generation sequencing identified novel heterozygous nonsense mutation in CNGB1 gene associated with retinitis pigmentosa in a Chinese patient
- Monogenic Retinal Diseases Associated With Genes Encoding Phototransduction Proteins: A Review
- Whole-exome sequencing identified genes known to be responsible for retinitis pigmentosa in 28 Chinese families
- The Genetic Landscape and Epidemiological Characteristics of Inherited Retinal Diseases in the Chinese Population
- Expanding the Clinical and Molecular Heterogeneity of Nonsyndromic Inherited Retinal Dystrophies
- Expanding the Genetic Landscape of Usher-Like Phenotypes
- Homozygosity mapping in autosomal recessive retinitis pigmentosa families detects novel mutations
- CNGB1 and Allied Disorders
- RP Hope — Genetic Testing (Newly Diagnosed)
- RP Hope — Clinical Trials Finder
- RP Hope — My RP Pathway
- RP Hope — Patient and Family Stories
Support, accessibility and family guidance(the same for every gene)
This guidance applies to anyone living with an inherited retinal condition, whichever gene is involved. Anything specific to this gene is in the section above.
- Ask before helping
- People differ widely in what assistance they want, and it changes by task and by day. Asking first respects that, and avoids help that gets in the way.
- Low-vision rehabilitation
- Low-vision specialists work on practical skills and tools for the sight someone has — lighting, contrast, magnification, orientation and mobility.
- Accessible technology
- Screen readers, magnification, high-contrast modes and voice control are built into phones and computers. Small settings changes often help sooner than new equipment.
- School and work
- Accommodations are often available well before vision loss is severe. Starting the conversation early usually makes it easier.
- Emotional and community support
- A genetic result affects the whole family. Connecting with others living with RP helps people feel less alone with it.
- Genetic counselling
- A genetic counsellor can explain what a result means for relatives, and what testing options exist, without anyone being pushed into a decision.
Medical disclaimer: This page is for education and navigation only — not medical advice, diagnosis, or treatment. These summaries are paraphrases of published research; always confirm details with a qualified clinician and primary sources.
